Smart Money Alert

Rubicon Research Limited

DecreasedInsider

RUBICONHealthcareMarket Cap₹25K Cr

Deal value

₹1.23 Cr

Stake

0.03%

6,796

Trade date

8 Sept 2026

Since alert−15.6%₹1,766.70 → ₹1,490.30

Nifty 50−2.0%

GIRISH SUBRAMANIAM IYER

Insider

The move

Girish Subramaniam Iyer sold 6,796 shares of Rubicon Research for ₹1.23 Cr at ₹1,817.05 apiece through a market sale, reducing his holding to 48,220 shares.

About Rubicon Research Limited

+ Follow Visit stock

A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.

Get the next move the moment it happens.

Follow the investors and Rubicon Research Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Rubicon Research Limited shareholders All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Rubicon Research Limited

NomuraDecreased

Nomura trimmed its stake in Rubicon Research from 1.35% to 1.10% by selling 4,12,160 shares. Following the transaction, its holding stands at 18,27,735 shares.

19 Oct 2026

HDFC Mutual FundNew position

HDFC Mutual Fund added over 2.5% of Rubicon Research during the quarter, holding 57,88,498 shares or 3.50% by the period's end.